Michelle S. Siegert is the VP of Fin. and Principal Financial & Accounting Officer at Pulmatrix Inc.
As the VP of Fin. and Principal Financial & Accounting Officer of Pulmatrix Inc, the total compensation of Ms Siegert at Pulmatrix Inc is $390,342. There are 3 executives at Pulmatrix Inc getting paid more, with Teofilo Raad having the highest compensation of $823,367.
Ms Siegert is 60, she's been the VP of Fin. and Principal Financial & Accounting Officer of Pulmatrix Inc since . There are 6 older and 8 younger executives at Pulmatrix Inc. The oldest executive at Pulmatrix Inc is Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD, 72, who is the Founder & Member of Scientific Advisory Board.
Michelle's mailing address filed with the SEC is C/O PULMATRIX, INC., 99 HAYDEN AVE, , LEXINGTON, MA, 02421.
Over the last 9 years, insiders at Pulmatrix Inc have traded over $4,537,500 worth of Pulmatrix Inc stock and bought 290,998 units worth $2,002,066 . The most active insiders traders include Steven Gillis, Terrance Mcguire und Innovative Sciences, Inc. O.... On average, Pulmatrix Inc executives and independent directors trade stock every 92 days with the average trade being worth of $521,728. The most recent stock trade was executed by David L. Hava on 20 March 2017, trading 2,263 units of PULM stock currently worth $5,001.
pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. the platform, called isperse (inhaled small particles easily respirable and emitted), represents a new paradigm in inhaled drug delivery based on unique properties: dense, high drug load engineered particles with highly efficient dispersibility and delivery to the airways. the isperse powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance.
Pulmatrix Inc executives and other stock owners filed with the SEC include: